ReWalk Robotics Stock (NASDAQ:LFWD)


ForecastRevenueFinancialsChartTranscripts

Previous Close

$1.50

52W Range

$1.41 - $9.10

50D Avg

$2.11

200D Avg

$3.67

Market Cap

$13.12M

Avg Vol (3M)

$54.44K

Beta

2.08

Div Yield

-

LFWD Company Profile


ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

IL

Employees

108

IPO Date

Sep 12, 2014

Website

LFWD Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceSep 24Jun 24
Product$4.80M$5.13M

Fiscal year ends in Dec 23 | Currency in USD

LFWD Financial Summary


Dec 23Dec 22Dec 21
Revenue$13.85M$5.51M$5.97M
Operating Income$-23.61M$-19.10M$-12.65M
Net Income$-22.13M$-19.57M$-12.74M
EBITDA$-21.90M$-18.92M$-12.43M
Basic EPS$-0.37$-0.31$-0.27
Diluted EPS$-0.37$-0.31$-0.27

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q3 24Nov 12, 24 | 11:30 AM
Q2 24Aug 15, 24 | 1:07 PM
Q1 24May 15, 24 | 12:00 AM